TNYA Stock Analysis: Buy, Sell, or Hold?
TNYA - Tenaya Therapeutics, Inc. Common Stock
$0.62
-0.05 (-6.78%)
▼
5d:
-17.5%
30d:
+10.36%
90d:
-17.78%
WAIT
LOW Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 06, 2026
Smart Money Accumulation
TNYA is down 9.8% this week, but smart money is accumulating calls. Top strike: $1 2026-05-15 with 183 OI. Call ratio: 100% View Scanner →
Strength: 9.8/10
Get Alerted When TNYA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: TNYA is down 17.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: TNYA is down 17.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: TNYA is currently trading at $0.62, which is considered slightly low relative to its 30-day fair value range of $0.60 to $0.85. From a valuation perspective, the stock is trading at a discount (Forward PE: -1.5) compared to its historical average (10.3). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, TNYA is in a strong uptrend. The price is currently testing key support at $0.65. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 6.8% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $9.00 (+1253.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TNYA is in a strong uptrend. The price is currently testing key support at $0.65. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 6.8% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $9.00 (+1253.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$0.60 -
$0.85
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-6.8%)
- BULLISH: Trading 1253.2% below Wall St target ($9.00)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- WARNING: Recommendation downgraded due to -17.5% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$0.60 -
$0.85
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.65
Resistance Level
$0.87
Current Trend
Strong Uptrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.47
Wall Street Target
$9.00
(+1253.2%)
PE vs Historical
-1.5 vs 10.3
CHEAP
Share & Embed Analysis
Last updated: March 30, 2026 3:06 PM ET
Data refreshes hourly during market hours. Next update: 4:06 PM
Data refreshes hourly during market hours. Next update: 4:06 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TNYA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
10
Sells
Net
INSIDERS SELLING
Recent Transactions
Group Gp Lp Column III
SELL
3511826 shares
2026-02-25
Group Gp Lp Column III
SELL
658440 shares
2026-02-24
Faraz Ali
SELL
14862 shares
2026-02-17
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$25 | 52 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$411 | 48 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$213 | 67 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$111 | 57 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 48 HOLD |
